As of the 16th November 2021 we are unable to process any online orders. We anticipate the service will be back up shortly.
We apologise for any inconvenience

Drugs Affecting Lipid Metabolism: Risks Factors and Future Directions

Author:   Ann S. Jackson ,  Antonio M. Gotto Jr. ,  Rodolfo Paoletti ,  Louis C. Smith
Publisher:   Springer
Edition:   1996 ed.
Volume:   10
ISBN:  

9780792341673


Pages:   710
Publication Date:   31 August 1996
Format:   Hardback
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Our Price $1132.56 Quantity:  
Add to Cart

Share |

Drugs Affecting Lipid Metabolism: Risks Factors and Future Directions


Add your own review!

Overview

Even a brief scan of the table of contents of the present volume is enough to disclose the diversity of research interests and opinions in the field of lipidology. It is precisely this diversity that is the strength of our field and that was showcased by the XII International Symposium of DRUGS AFFECTING LIPID METABOLISM (DALM). The papers published here from these proceedings may be divided into three categories: those that define-and refine---our understanding ofthe clinical benefit of aggressive lipid management, those that develop our knowledge of ris!. assessment, and those that discuss the genetic, bio~hemical, and biophysical mechanisms underlying the pathology of coronary heart disease. On the clinical front, further analysis of the results of the Scandinavian Simvastatin Survival Study (4S) has indicated the cost-effectiveness of therapy in patients with established coronary heart disease. The West of Scotland Coronary Prevention Study (WOSCOPS), whose methodology was described at the DALM XII symposium, has demonstrated in a mostly primary-prevention population what 4S demonstrated for secondary prevention the year before: aggressive lipid-regulating therapy reduces coronary heart disease morbidity and mortality rates without concurrently increasing mortality from noncardiovascular causes. In the future, important considerations will be to develop protocols that maximize benefit in groups underrepresented in traditional clinical research for example, women and the elderly-and to improve compliance to existing treatment regimens. Furthermore, antioxidant, omega-3 fatty acid, and gene therapies warrant further investigation.

Full Product Details

Author:   Ann S. Jackson ,  Antonio M. Gotto Jr. ,  Rodolfo Paoletti ,  Louis C. Smith
Publisher:   Springer
Imprint:   Springer
Edition:   1996 ed.
Volume:   10
Weight:   1.420kg
ISBN:  

9780792341673


ISBN 10:   0792341678
Pages:   710
Publication Date:   31 August 1996
Audience:   College/higher education ,  Professional and scholarly ,  Undergraduate ,  Postgraduate, Research & Scholarly
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

 lw

ls 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List